SEATTLE, Aug. 26 (UPI) -- The hormone tamoxifen decreases breast cancer survivors' risk of one cancer, but may increase risk for another cancer type, U.S. researchers said.
CARDIFF, Wales, Jan. 18 (UPI) -- Scientists in Wales may have uncovered why certain patients develop resistance to tamoxifen treatments for breast cancer.
COPENHAGEN, Denmark, Dec. 26 (UPI) -- Breast cancer patients given chemotherapy and tamoxifen have a reduced risk of developing a second cancer in the other breast, a Danish researcher found.
DETROIT, April 30 (UPI) -- Breast-cancer cells that express estrogen receptor can be treated with tamoxifen only as long as they remain sensitive to the drug, says a U.S. study.
BETHESDA, Md., Nov. 30 (UPI) -- African American and Caucasian women treated with tamoxifen for breast cancer appear to have the same risks of getting cancer in the opposite breast.
WASHINGTON, June 10 (UPI) -- Georgetown University researchers said they have linked the gene IRF 1 to breast tumor resistance that is commonly developed to the drug tamoxifen.
IOWA CITY, Iowa, Jan. 30 (UPI) -- University of Iowa researchers now have a better grasp of the workings of tamoxifen, a widely used breast cancer therapy.
LONDON, Sept. 12 (UPI) -- The International Breast Cancer Intervention Study trial of tamoxifen, which includes 7,000 women at high risk for breast cancer, Thursday reported results that
LONDON, March 20 (UPI) -- Senior researchers Wednesday gave a cautious welcome to preliminary study results that show the drug tamoxifen could cut the incidence of breast cancer in high-risk healthy women. The study was presented at the third European Breast Cancer Conference in B
SAN ANTONIO, Dec. 10 (UPI) --
